Systems proteomics for translational network medicine.

Proteomics encompasses diverse methods by which to study proteins, their abundance, structure, posttranslational modifications, and physical or functional interacting partners to map the proteome, the protein complement of a genome. Although such methods can be applied to individual proteins, proteomics facilitates large-scale analysis of complete proteomes or targeted subproteomes (Table 1). Moreover, proteomics enables comparisons between distinct conditions/states, from defined biological sources, across discrete timelines. In general, a proteomic cartography pipeline involves sample acquisition, followed by protein isolation, separation, resolution, and identification (Figure). Along this continuum, each successive module harbors a multistep process, whereby proteomic methodologies can be implemented. Figure. Network systems proteomic pipeline. Strategy extending proteomic profiling from mapping and quantification of protein identities to ontological categorization, pathway analysis and network generation for inclusive systems interpretation. View this table: Table 1. Systems Proteomics Lexicon Once proteins are isolated from the source of interest, 2 major separation strategies have evolved to address proteome complexity.1,2 Traditional gel-based approaches, particularly 2-dimensional gel electrophoresis involving isoelectric focusing followed orthogonally by sodium dodecyl sulfate - polyacrylamide gel electrophoresis, were the earliest methods adopted for protein separation and resolution, comparative assessment of relative abundance, and initial reduction of protein complexity before mass spectrometry (MS). Although 2-dimensional gel electrophoresis remains common, the advent of quantitative MS techniques has led to increased application of various gel-based and gel-free alternatives, whereby protein or peptide complexity is addressed by separation and resolution before or in conjunction with MS, whereas quantification is subsequently measured from MS precursor or fragment ion spectra. Choice of separation strategy is influenced by study objectives and resources, often guided by advantages and limitations to each approach. Quantitative MS methods tend to be less time- and labor-intensive while offering greater potential throughput and data acquisition, yet in instances where 2-dimensional gel electrophoresis approaches are applied in parallel, use of …

[1]  W. Robb MacLellan,et al.  Systems-based approaches to cardiovascular disease , 2012, Nature Reviews Cardiology.

[2]  Y. Levin The role of statistical power analysis in quantitative proteomics , 2011, Proteomics.

[3]  Alexey I Nesvizhskii,et al.  Interpretation of Shotgun Proteomic Data , 2005, Molecular & Cellular Proteomics.

[4]  Peipei Ping,et al.  Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. , 2006, Journal of the American College of Cardiology.

[5]  D. K. Arrell,et al.  ATP‐Sensitive K+ Channel‐Deficient Dilated Cardiomyopathy Proteome Remodeled by Embryonic Stem Cell Therapy , 2010, Stem cells.

[6]  Mark E. J. Newman,et al.  The Structure and Function of Complex Networks , 2003, SIAM Rev..

[7]  David P. Nusinow,et al.  Networked-based characterization of extracellular matrix proteins from adult mouse pulmonary and aortic valves. , 2011, Journal of proteome research.

[8]  C. Hollenbeak,et al.  Functional proteomic analysis reveals sex-dependent differences in structural and energy-producing myocardial proteins in rat model of alcoholic cardiomyopathy. , 2011, Physiological genomics.

[9]  D. K. Arrell,et al.  Proteomic Analysis of Pharmacological Preconditioning: Novel Protein Targets Converge to Mitochondrial Metabolism Pathways , 2006, Circulation research.

[10]  Molecular Therapeutics From Knowledge to Delivery , 2010, Clinical pharmacology and therapeutics.

[11]  S. Chien,et al.  PDGF-BB and TGF-β1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress , 2011, Proceedings of the National Academy of Sciences.

[12]  Ronald J. Moore,et al.  Differential Label-free Quantitative Proteomic Analysis of Shewanella oneidensis Cultured under Aerobic and Suboxic Conditions by Accurate Mass and Time Tag Approach*S , 2006, Molecular & Cellular Proteomics.

[13]  Jennifer E Van Eyk,et al.  Overview: The Maturing of Proteomics in Cardiovascular Research , 2011, Circulation research.

[14]  B. Weimer,et al.  Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. , 2010, Cardiovascular research.

[15]  Andre Terzic,et al.  K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy. , 2011, Cardiovascular research.

[16]  Leroy Hood,et al.  The impact of systems approaches on biological problems in drug discovery , 2004, Nature Biotechnology.

[17]  T. Pawson,et al.  Network medicine , 2008, FEBS letters.

[18]  A. Didangelos,et al.  Proteomics Analysis of Cardiac Extracellular Matrix Remodeling in a Porcine Model of Ischemia/Reperfusion Injury , 2012, Circulation.

[19]  R. Gomis,et al.  Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses , 2011, Journal of thrombosis and haemostasis : JTH.

[20]  Albert,et al.  Emergence of scaling in random networks , 1999, Science.

[21]  Nicole K Henderson-Maclennan,et al.  Pathway analysis software: annotation errors and solutions. , 2010, Molecular genetics and metabolism.

[22]  A. Terzic,et al.  Genomic chart guiding embryonic stem cell cardiopoiesis , 2008, Genome Biology.

[23]  Manuel Mayr,et al.  Proteomic and Metabolomic Analysis of Smooth Muscle Cells Derived From the Arterial Media and Adventitial Progenitors of Apolipoprotein E–Deficient Mice , 2008, Circulation research.

[24]  D. K. Arrell,et al.  Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.

[25]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[26]  D. K. Arrell,et al.  ATP-sensitive K+ channel knockout induces cardiac proteome remodeling predictive of heart disease susceptibility. , 2009, Journal of proteome research.

[27]  Martin Kuiper,et al.  BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..

[28]  E. Calvo,et al.  Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. , 2012, Journal of proteomics.

[29]  Andre Terzic,et al.  Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. , 2011, Cell metabolism.

[30]  Euan A. Ashley,et al.  Gene Coexpression Network Topology of Cardiac Development, Hypertrophy, and Failure , 2011, Circulation. Cardiovascular genetics.

[31]  M. Emmett,et al.  High-sensitivity electron capture dissociation tandem FTICR mass spectrometry of microelectrosprayed peptides. , 2001, Analytical chemistry.

[32]  G. West,et al.  The importance of quantitative systemic thinking in medicine , 2012, The Lancet.

[33]  A. Chambery,et al.  Proteomic profiling of medial degeneration in human ascending aorta. , 2010, Clinical biochemistry.

[34]  Albert-László Barabási,et al.  Error and attack tolerance of complex networks , 2000, Nature.

[35]  Ying Ge,et al.  Comprehensive Analysis of Protein Modifications by Top-Down Mass Spectrometry , 2011, Circulation. Cardiovascular genetics.

[36]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[37]  B. Chait Mass Spectrometry: Bottom-Up or Top-Down? , 2006, Science.

[38]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[39]  K. Reardon,et al.  Concentration-dependent effects of the soy phytoestrogen genistein on the proteome of cultured cardiomyocytes. , 2012, Journal of proteomics.

[40]  Michael E Phelps,et al.  Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.

[41]  Qingbo Xu,et al.  Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. , 2009, Journal of molecular and cellular cardiology.

[42]  D. Hochstrasser,et al.  Improved and simplified in‐gel sample application using reswelling of dry immobilized pH gradients , 1997, Electrophoresis.

[43]  Uwe Völker,et al.  Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies. , 2011, Journal of proteome research.

[44]  D. K. Arrell,et al.  Cardioinductive Network Guiding Stem Cell Differentiation Revealed by Proteomic Cartography of Tumor Necrosis Factor α‐Primed Endodermal Secretome , 2008, Stem cells.

[45]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[46]  Toward a holistic view of transcriptional regulation. , 2011, Circulation. Cardiovascular genetics.

[47]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[48]  Rebekah L. Gundry,et al.  Expanding the mouse embryonic stem cell proteome: Combining three proteomic approaches , 2010, Proteomics.

[49]  D. K. Arrell,et al.  Cardiovascular proteomics: evolution and potential. , 2001, Circulation research.

[50]  A. Makarov,et al.  The Orbitrap: a new mass spectrometer. , 2005, Journal of mass spectrometry : JMS.

[51]  S. Sperling Systems biology approaches to heart development and congenital heart disease. , 2011, Cardiovascular research.

[52]  A. Lusis,et al.  Cardiovascular networks: systems-based approaches to cardiovascular disease. , 2010, Circulation.

[53]  M. Mayr,et al.  Profiling of circulating microRNAs: from single biomarkers to re-wired networks , 2011, Cardiovascular research.

[54]  Sui Huang,et al.  Cell Lineage Determination in State Space: A Systems View Brings Flexibility to Dogmatic Canonical Rules , 2010, PLoS biology.

[55]  M. Dunn,et al.  Proteomics of the Heart : Unraveling Disease , 2006 .

[56]  M. Zile,et al.  Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus. , 2009, Journal of proteome research.

[57]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[58]  J. Eyk Overview: the maturing of proteomics in cardiovascular research. , 2011 .

[59]  Leroy Hood,et al.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.

[60]  D. K. Arrell,et al.  Cardiopoietic programming of embryonic stem cells for tumor-free heart repair , 2007, The Journal of experimental medicine.

[61]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[62]  Pascale Kuntz,et al.  GVSR: An On-Line Guide for Choosing a Graph Visualization Software , 2010, Graph Drawing.

[63]  Brian T Chait,et al.  Chemistry. Mass spectrometry: bottom-up or top-down? , 2006, Science.

[64]  Q. Cui,et al.  Proteomic analysis of metabolic, cytoskeletal and stress response proteins in human heart failure , 2011, Journal of cellular and molecular medicine.

[65]  D. Hochstrasser,et al.  Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. , 2008, Analytical chemistry.

[66]  Timothy J. Nelson,et al.  Cardiogenic Induction of Pluripotent Stem Cells Streamlined Through a Conserved SDF-1/VEGF/BMP2 Integrated Network , 2010, PloS one.

[67]  Ángel García,et al.  Proteins Involved in Platelet Signaling Are Differentially Regulated in Acute Coronary Syndrome: A Proteomic Study , 2010, PloS one.

[68]  Gary D Bader,et al.  Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps , 2010, Proteomics.

[69]  J. Macri,et al.  Application of proteomics to the study of cardiovascular biology. , 2001, Trends in cardiovascular medicine.

[70]  D. K. Arrell,et al.  Proteomic profiling of KATP channel‐deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome , 2009, Proteomics.

[71]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[72]  Christophe Ladroue,et al.  Comparative Lipidomics Profiling of Human Atherosclerotic Plaques , 2011, Circulation. Cardiovascular genetics.

[73]  Simon C. F. Sheng,et al.  Milk Fat Globule Protein Epidermal Growth Factor-8: A Pivotal Relay Element Within the Angiotensin II and Monocyte Chemoattractant Protein-1 Signaling Cascade Mediating Vascular Smooth Muscle Cells Invasion , 2009, Circulation research.

[74]  M. Ünlü,et al.  Difference gel electrophoresis. A single gel method for detecting changes in protein extracts , 1997, Electrophoresis.

[75]  D. Noble,et al.  Systems Biology: An Approach , 2010, Clinical pharmacology and therapeutics.

[76]  C. Stoeckert,et al.  Coronary Artery Endothelial Transcriptome In Vivo: Identification of Endoplasmic Reticulum Stress and Enhanced Reactive Oxygen Species by Gene Connectivity Network Analysis , 2011, Circulation. Cardiovascular genetics.

[77]  Shuying Liu,et al.  Proteomic profiling reveals comprehensive insights into adrenergic receptor‐mediated hypertrophy in neonatal rat cardiomyocytes , 2009, Proteomics. Clinical applications.

[78]  Melanie Y. White,et al.  Phosphoproteomic profiling of the myocyte. , 2011, Circulation. Cardiovascular genetics.

[79]  A. Barabasi,et al.  Systems biology and the future of medicine , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[80]  Gary D. Bader,et al.  Pathguide: a Pathway Resource List , 2005, Nucleic Acids Res..

[81]  C. Runowicz,et al.  The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer. , 2010, Gynecologic oncology.

[82]  Gary D Bader,et al.  How to visually interpret biological data using networks , 2009, Nature Biotechnology.

[83]  Michael L. Creech,et al.  Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.

[84]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[85]  Ermir Qeli,et al.  A Mighty Small Heart: The Cardiac Proteome of Adult Drosophila melanogaster , 2011, PloS one.

[86]  Timothy J. Nelson,et al.  Decoded Calreticulin‐Deficient Embryonic Stem Cell Transcriptome Resolves Latent Cardiophenotype , 2010, Stem cells.

[87]  Albert-László Barabási,et al.  MicroRNA-21 Integrates Pathogenic Signaling to Control Pulmonary Hypertension: Results of a Network Bioinformatics Approach , 2012, Circulation.

[88]  D. Kass,et al.  Modulation of Mitochondrial Proteome and Improved Mitochondrial Function by Biventricular Pacing of Dyssynchronous Failing Hearts , 2010, Circulation. Cardiovascular genetics.